AstraZeneca has completed a Phase IIb heart failure trial for AZD5462, finished a real-world breast cancer study in Brazil, and is recruiting for an observational COPD study in heart clinic patients.
DelveInsight releases three separate pipeline reports covering metastatic prostate cancer (80+ companies, 85+ drugs), iPSC-derived NK cells (12+ companies, 15+ drugs), and interstitial lung diseases (120+ companies, 120+ drugs), highlighting recent regulatory approvals, trial launches, and emerging therapies.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07489066 |
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC |
NOT_YET_RECRUITING | PHASE2 |
| NCT07451899 |
TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease |
RECRUITING | |
| NCT07046234 |
Point of Care Lung Ultrasound Examination in Patients With Shortness of Breath |
ENROLLING_BY_INVITATION | NA |
| NCT06727370 |
Cognitive Screening in Lung Cancer Patients |
RECRUITING | |
| NCT06622668 |
NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease |
WITHDRAWN | PHASE1/PHASE2 |
| NCT05933694 |
Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software |
RECRUITING | NA |
| NCT03816059 |
Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications |
UNKNOWN | |
| NCT03085069 |
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC |
UNKNOWN | PHASE2 |
| NCT03017976 |
Swimming Pool Environment Impact on the Human Respiratory Health |
UNKNOWN | |
| NCT02965300 |
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis |
UNKNOWN |
